Evidence map›Paper›PMID 38297980›Full record

ArticleHuman molecular genetics2024

Excessive tubulin glutamylation leads to progressive cone-rod dystrophy and loss of outer segment integrity.

Rawaa Aljammal, Thamaraiselvi Saravanan, Tongju Guan, Scott Rhodes, Michael A Robichaux, Visvanathan Ramamurthy

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Ciliary ARL13B Is Essential for Vision and Morphogenesis of Cone Outer Segments.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rawaa AljammalDepartment of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, 64 Medical Center Dr., Morgantown, WV 26506, United States.
Thamaraiselvi SaravananDepartment of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, 64 Medical Center Dr., Morgantown, WV 26506, United States.
Tongju GuanDepartment of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, 64 Medical Center Dr., Morgantown, WV 26506, United States.
Scott RhodesDepartment of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, 64 Medical Center Dr., Morgantown, WV 26506, United States.
Michael A RobichauxDepartment of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, 64 Medical Center Dr., Morgantown, WV 26506, United States.
Visvanathan RamamurthyDepartment of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, 64 Medical Center Dr., Morgantown, WV 26506, United States.ORCID 0000-0003-0289-3685
West Virginia University · US

Funding

VS-CoBRE Administrative CoreP20GM144230 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Amanda Susanne Gatesman-Ammer · 2022 to 2026
$13.9M
Importance of Small GTPases in Photoreceptor FunctionR01EY028035 · NEI · WEST VIRGINIA UNIVERSITY · PI Visvanathan Ramamurthy · 2017 to 2026
$3.2M
Cell and Molecular Biology Training Program at West Virginia UniversityT32GM133369 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Zoica Cerasela Dinu, MICHAEL D SCHALLER · 2019 to 2026
$2.0M
Biosynthesis and trafficking of phosphodiesterase in the retinal photoreceptorsR01EY031346 · NEI · WEST VIRGINIA UNIVERSITY · PI RAMAMURTHY, VISVANATHAN · 2020 to 2024
$1.9M
Mechanism behind blindness linked to excess glutamylationF31EY031964 · NEI · WEST VIRGINIA UNIVERSITY · PI ALJAMMAL, RAWAA · 2021 to 2022
$93k
NEI NIH HHS F31 EY031964NEI NIH HHS R01 EY028035NEI NIH HHS R01 EY031346NIGMS NIH HHS P20 GM144230NIGMS NIH HHS T32 GM133369NIH Individual Predoctoral Fellows F31EY031964NIH Institutional Research Training T32GM133369Visual Sciences Center of Biomedical Research Excellence P20GM144230
6 · The paper itself

Abstract

Mutations in Cytosolic Carboxypeptidase-like Protein 5 (CCP5) are associated with vision loss in humans. To decipher the mechanisms behind CCP5-associated blindness, we generated a novel mouse model lacking CCP5. In this model, we found that increased tubulin glutamylation led to progressive cone-rod dystrophy, with cones showing a more pronounced and earlier functional loss than rod photoreceptors. The observed functional reduction was not due to cell death, levels, or the mislocalization of major phototransduction proteins. Instead, the increased tubulin glutamylation caused shortened photoreceptor axonemes and the formation of numerous abnormal membranous whorls that disrupted the integrity of photoreceptor outer segments (OS). Ultimately, excessive tubulin glutamylation led to the progressive loss of photoreceptors, affecting cones more severely than rods. Our results highlight the importance of maintaining tubulin glutamylation for normal photoreceptor function. Furthermore, we demonstrate that murine cone photoreceptors are more sensitive to disrupted tubulin glutamylation levels than rods, suggesting an essential role for axoneme in the structural integrity of the cone outer segment. This study provides valuable insights into the mechanisms of photoreceptor diseases linked to excessive tubulin glutamylation.

Indexed as

Cone-Rod DystrophiesTubulinAnimalsHumansMiceMutationRetinal Cone Photoreceptor CellsRetinal Rod Photoreceptor CellsTubulinblindnessphotoreceptorsprotein posttranslational modificationretinal degenerationtubulin modification

Identifiers

PMID38297980
PMCPMC12099296
OpenAlexW4391446495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.